Atlas company financials

CVS HEALTH Corp

Standardized 19-year financial series for CVS HEALTH Corp, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000064803FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$402.1B

Adjusted EBITDA

—

Net result

$1.8B

Net financial debt

-$8.5B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$102.9B

TTM revenue

$391.8B

TTM free cash flow

—

Latest quarter net result

-$4B

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 9.3%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · cvs-health-corp-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-02-26 · Retrieved: 2026-04-26T11:39:25.242930+00:00
SEC EDGAR companyfacts
us-gaap:InterestExpense · us gaap companyfacts · comparative · cvs-health-corp-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-18 · Retrieved: 2026-04-26T11:39:25.242930+00:00
SEC EDGAR companyfacts
primary · cvs-health-corp-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-17 · Retrieved: 2026-04-26T11:39:25.242930+00:00
SEC EDGAR companyfacts
primary · cvs-health-corp-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-15 · Retrieved: 2026-04-26T11:39:25.242930+00:00
SEC EDGAR companyfacts
primary · cvs-health-corp-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-11 · Retrieved: 2026-04-26T11:39:25.242930+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	76B	—	5B	3B	3B	-2B	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing interest expense · missing inventory · missing net financial debt · missing research and development · missing sg and a · missing total assets
FY2008	87B	—	6B	3B	4B	-2B	10B	comparative annual fact carried from later 10k · missing adjusted ebitda · missing research and development · missing sg and a
FY2009	99B	—	6B	4B	4B	-3B	10B	missing adjusted ebitda · missing research and development · missing sg and a
FY2010	96B	—	6B	3B	5B	-2B	9B	missing adjusted ebitda · missing research and development · missing sg and a
FY2011	107B	—	6B	—	6B	-2B	9B	missing adjusted ebitda · missing net result · missing research and development · missing sg and a
FY2012	123B	—	7B	—	7B	-2B	8B	missing adjusted ebitda · missing net result · missing research and development · missing sg and a
FY2013	127B	—	8B	—	6B	-2B	9B	missing adjusted ebitda · missing net result · missing research and development · missing sg and a
FY2014	139B	—	9B	5B	8B	-2B	10B	missing adjusted ebitda · missing research and development · missing sg and a
FY2015	153B	—	9B

Filing provenance